Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai OPM Biosciences CoSHSE:688293 +3.94%77 EV-to-EBITDA is 64.61 as of Sep. 09, 2026, which is 4% above its 10-year median of 62.27. GuruFocus rates SHSE:688293 with a GF Score™ of 77/100 and a GF Value™ of ¥46.66 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 400 Biotechnology companies, Shanghai OPM Biosciences Co ranks worse than 81.75% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Shanghai OPM Biosciences Co's enterprise value is ¥8,779.2 Mil.
Shanghai OPM Biosciences Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ¥135.9 Mil. Therefore, Shanghai OPM Biosciences Co's EV-to-EBITDA for today is 64.61.
The historical rank and industry rank for Shanghai OPM Biosciences Co's EV-to-EBITDA or its related term are showing as below:
SHSE:688293'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 28.33 Med: 62.27 Max: 417.49
Current: 55.52
During the past 8 years, the highest EV-to-EBITDA of Shanghai OPM Biosciences Co was 417.49. The lowest was 28.33. And the median was 62.27.
SHSE:688293's EV-to-EBITDA is ranked worse than 81.75% of 400
companies
in the Biotechnology industry
Industry Median: 13.615
vs SHSE:688293: 55.52
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Shanghai OPM Biosciences Co (SHSE:688293) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai OPM Biosciences Co's PE Ratio (TTM) for today is calculated as:
Shanghai OPM Biosciences Co's share price for today is ¥70.98.
Shanghai OPM Biosciences Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.697.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688293 vs VRTX, REGN, MRNA: EV-to-EBITDA Comparison
For the Biotechnology subindustry, Shanghai OPM Biosciences Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai OPM Biosciences Co EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai OPM Biosciences Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Shanghai OPM Biosciences Co's EV-to-EBITDA falls into.
Shanghai OPM Biosciences Co's current Enterprise Value is ¥8,779.2 Mil.
Shanghai OPM Biosciences Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥135.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai OPM Biosciences Co (SHSE:688293) has a EV-to-EBITDA of 64.61 as of Sep. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shanghai OPM Biosciences Co. This is near median its historical median of 62.27. Over the past decade, Shanghai OPM Biosciences Co's EV-to-EBITDA has ranged from 28.33 to 417.49. According to the industry distribution chart, Shanghai OPM Biosciences Co ranks #327 out of 400 companies in the Biotechnology industry, placing it in the top 81.7%.
Is Shanghai OPM Biosciences Co's EV-to-EBITDA too high?
Shanghai OPM Biosciences Co's current EV-to-EBITDA of 64.61 is near median its 10-year median of 62.27. Over the past 10 years, this metric has ranged from a low of 28.33 to a high of 417.49. The Biotechnology industry median EV-to-EBITDA is 13.62. Shanghai OPM Biosciences Co's value of 64.61 is 374.6% above this industry median. Based on the distribution chart, Shanghai OPM Biosciences Co ranks #327 out of 400 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shanghai OPM Biosciences Co has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai OPM Biosciences Co's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai OPM Biosciences Co ranks #327 out of 400 companies for EV-to-EBITDA. This places Shanghai OPM Biosciences Co in the lower half of its industry. The industry median EV-to-EBITDA is 13.62. Shanghai OPM Biosciences Co's value of 64.61 is 374.6% above this benchmark. Historically, Shanghai OPM Biosciences Co's own EV-to-EBITDA has ranged from 28.33 to 417.49 over the past decade. While the company's 10-year median is 62.27 vs. the industry median of 13.62, Shanghai OPM Biosciences Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.62, based on 400 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai OPM Biosciences Co's current EV-to-EBITDA of 64.61 is 374.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Shanghai OPM Biosciences Co. For the Biotechnology industry, the median EV-to-EBITDA is 13.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai OPM Biosciences Co's current EV-to-EBITDA is 64.61, which is near median its own 10-year median of 62.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai OPM Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co (SHSE:688293) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥46.66, compared to a current price of ¥70.98 — trading 52.1% above its estimated fair value. The current EV-to-EBITDA is 64.61, which is near median its 10-year median of 62.27 and 374.6% above the Biotechnology industry median of 13.62. Shanghai OPM Biosciences Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Shanghai OPM Biosciences Co (SHSE:688293), the current EV-to-EBITDA is 64.61 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai OPM Biosciences Co (SHSE:688293) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co stock appears to be overvalued.
The current stock price of ¥70.98 is trading 52.1% above its estimated GF Value™ of ¥46.66.
GuruFocus considers Shanghai OPM Biosciences Co to be Significantly Overvalued.
Key valuation signals for SHSE:688293:
EV-to-EBITDA: 64.61 (near median its 10-year median of 62.27)
GF Value™: ¥46.66 vs. price of ¥70.98 (52.1% above fair value)
Industry Position: 374.6% above the Biotechnology median (#327 of 400)
No single metric tells the full story. See the SHSE:688293 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688293 has been successfully added to your 
